Abstract

It is well known that community awareness of hepatitis B (HB) can lead to vaccination and testing. The study objectives were to assess the prevalence of HBV infection and knowledge of HB among adult patients attending randomly selected primary care clinics. A cross-sectional sero-survey was conducted in March 2013 in the Zgorzelec region, Poland, with the use of an investigator-developed questionnaire containing 22 questions regarding HB knowledge. Serum samples were assayed for anti-HBc total and anti-HBs with enzyme immunoassay. The prevalence of anti-HBc total among 410 participants (median age 56 years) was 10.3 % (95 % CI 7.6–13.8 %), nobody was aware of an infection. The main sources of HB knowledge were the media and medical staff. The mean knowledge score was 14.8 ± 4.9; 76.7 % of the respondents had scores >50 %. Particular gaps were detected relating to knowledge of unprotected sexual intercourse and MTCT; 45.6 % patients were not aware of the potential asymptomatic course of HBV infection, 41.2 % about chronic HB treatment. A patient’s low educational level was negatively associated with a high knowledge level; the willingness for further education on HB and HBV vaccination in the past were independently associated with good knowledge. In conclusion, the HBV infection remains a public health threat in Poland, since the prevalence of infection markers in asymptomatic adult patients was high. Knowledge gaps call for awareness campaigns which may increase testing and diagnosis, audiences representing lower education level should be targeted first. Knowledge on HB might serve as an effective tool in decision making regarding vaccination.

Highlights

  • Hepatitis B virus (HBV) infection remains a major global health problem affecting all countries, including Poland

  • The study objectives were to assess the prevalence of HBV infection and knowledge of hepatitis B (HB) among adult patients attending randomly selected primary care clinics

  • Our primary outcome variable was HB knowledge and we aimed to identify patient characteristics associated with this outcome

Read more

Summary

Introduction

Hepatitis B virus (HBV) infection remains a major global health problem affecting all countries, including Poland. Approximately two billion people are infected with HBV, 248 million are HBsAg positive, with the seroprevalence 3.6 %. 780,000 persons die each year from hepatitis B (HB)— 650,000 from cirrhosis and hepatocellular carcinoma due to chronic infection and another 130,000 from acute HB [1, 2]. In Poland there are approximately 350,000–450,000 carriers (0.5–1.5 %) of HBsAg in the population [3]. The peak incidence in Poland occurred during the 1980s and has been declining since Despite this decline, approximately 1000-1500 new cases still occur each year with the incidence of about 4.0/100,000 [4]. In 2013 acute cases accounted for 5.3 % of all HB cases and there has been a continuing downward trend in the last few years in

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call